MTAC vs ABOS
Comparison between MedTech Acquisition Corp - Class A (MTAC, Company) and Acumen Pharmaceuticals Inc (ABOS, Company).
MTAC vs ABOS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
MTAC
$183M
Winner
ABOS
$183M
Max Drawdown
Winner
MTAC
13.92%
ABOS
95.56%
Sharpe Ratio
MTAC
0.44
Winner
ABOS
1.35
5Y Beta
MTAC
N/A
ABOS
1.45
Industry
MTAC
N/A
ABOS
Biotechnology
P/E Ratio
Winner
MTAC
-32.94
ABOS
-1.40
Debt to Equity
Winner
MTAC
0.00%
ABOS
35.49%
Free Cash Flow Yield
Winner
MTAC
-27.91%
ABOS
-57.53%
P/S Ratio
Winner
MTAC
12.43
ABOS
538.78
P/B Ratio
Winner
MTAC
-12.13
ABOS
2.10
MTAC vs ABOS - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MTAC
+7.90%
ABOS
-0.42%
3M
Winner
MTAC
+9.99%
ABOS
-28.18%
6M
MTAC
+11.55%
Winner
ABOS
+35.43%
1Y
MTAC
+14.55%
Winner
ABOS
+137.00%
5Y(CAGR)
MTAC
N/A
ABOS
-35.24%
Max(CAGR)
Winner
MTAC
+3.05%
ABOS
-35.24%
MTAC vs ABOS - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | MTAC | ABOS |
|---|---|---|
| 2026 | N/A | +17.33% |
| 2025 | N/A | +14.05% |
| 2024 | N/A | -59.34% |
| 2023 | +12.84% | -27.00% |
| 2022 | +0.80% | -19.76% |
| 2021 | -6.08% | -66.37% |
MTAC vs ABOS Drawdown Comparison
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The maximum drawdown for ABOS was -95.56%, occurring on Apr 17, 2025. This drawdown has not yet recovered.
The current ABOS drawdown is -88.31%.
| Rank | MTAC | ABOS |
|---|---|---|
| #1 | -13.92% Feb 19, 2021 - Aug 10, 2023 | -95.56% Jul 2, 2021 - Apr 17, 2025 |
| #2 | -1.90% Feb 8, 2021 - Feb 16, 2021 | N/A |
Correlation
Correlation between MTAC and ABOS is -0.24 which considered as a very weak or no correlation - the stocks move independently of each other.
-0.24
-101
Select Stocks to Compare
Popular: MTAC vs SPYABOS vs SPY
More Comparisons
Compare with similar stocks